XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.20.2

Share-Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Share-Based Compensation | Note 3. Share-Based Compensation We grant share-based compensation awards to our officers, directors, and certain key employees pursuant to the 2017 Viad Corp Omnibus Incentive Plan (the “2017 Plan”). The 2017 Plan has a 10-year term and provides for the following types of awards: (a) incentive and non-qualified stock options; (b) restricted stock awards and restricted stock units; (c) performance units or performance shares; (d) stock appreciation rights; (e) cash-based awards; and (f) certain other stock-based awards. In June 2017, we registered 1,750,000 shares of common stock issuable under the 2017 Plan. As of September 30, 2020, there were 1,077,197 shares available for future grant under the 2017 Plan. The following table summarizes share-based compensation (income) expense:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in thousands) |  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Performance unit incentive plan (“PUP”) |  | $ | 149 |  |  | $ | 1,033 |  |  | $ | (2,596 | ) |  | $ | 4,013 |
Restricted stock awards and restricted stock units |  |  | 1,698 |  |  |  | 798 |  |  |  | 3,155 |  |  |  | 2,435 |
Stock options |  |  | 90 |  |  |  | — |  |  |  | 90 |  |  |  | — |
Share-based compensation expense before income tax |  |  | 1,937 |  |  |  | 1,831 |  |  |  | 649 |  |  |  | 6,448 |
Income tax benefit(1) |  |  | — |  |  |  | (460 | ) |  |  | — |  |  |  | (1,625 | )
Share-based compensation expense, net of income tax |  | $ | 1,937 |  |  | $ | 1,371 |  |  | $ | 649 |  |  | $ | 4,823 |
(1) | There was no income tax benefit for the three and nine months ended September 30, 2020 due to the valuation allowance on our deferred tax assets. Refer to Note 16 – Income Taxes.
PUP Awards PUP awards are performance-based restricted stock units that are tied to our stock price and the expected achievement of certain performance-based criteria. The vesting of PUP award shares is based upon the achievement of the performance-based criteria over a three-year period. We account for PUP awards that will be settled in shares of our common stock as equity-based awards. We measure share-based compensation expense of equity-based awards at fair value on the grant date on a straight-line basis over the vesting period. The estimated number of shares to be achieved is updated each reporting period. We account for PUP awards that will be settled in cash as liability-based awards. We measure share-based compensation expense of liability-based awards at fair value at each reporting date until the date of settlement. Forfeitures are accounted for as they occur. During the nine months ended September 30, 2020, we granted PUP awards with a grant date fair value of $4.8 million of which $1.8 million are payable in shares. Liabilities related to PUP awards were $0.4 million as of September 30, 2020 and $5.3 million as of December 31, 2019. During the nine months ended September 30, 2020, the value of the PUP awards decreased due to the reduction of our estimated performance achievement and the decline in our stock price as a result of the COVID-19 pandemic. In 2020, PUP awards granted in 2017 vested and we paid $2.6 million in cash. No PUP awards were paid in shares in 2020. In 2019, PUP awards granted in 2016 vested and we paid $5.6 million in cash and $3.4 million in shares. In 2019, we withheld 25,771 shares for $1.5 million related to tax withholding requirements on vested PUP awards paid in shares. The following table summarizes the activity of the outstanding PUP awards:
|  | Equity-Based PUP Awards |  |  | Liability-Based PUP Awards |
|  | Shares |  |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  |  | Weighted-Average Grant Date Fair Value |
Balance at December 31, 2019 |  |  | 59,714 |  |  | $ | 52.10 |  |  |  | 155,190 |  |  | $ | 52.53 |
Granted |  |  | 32,367 |  |  | $ | 56.23 |  |  |  | 52,531 |  |  | $ | 56.10 |
Vested |  |  | — |  |  | $ | — |  |  |  | (67,866 | ) |  | $ | 47.43 |
Forfeited |  |  | — |  |  | $ | — |  |  |  | (18,370 | ) |  | $ | 56.40 |
Balance at September 30, 2020 |  |  | 92,081 |  |  | $ | 55.49 |  |  |  | 121,485 |  |  | $ | 55.08 |
Restricted Stock Awards and Restricted Stock Units Restricted stock awards and restricted stock units are service-based awards. We account for restricted stock awards and restricted stock units that will be settled in shares of our common stock as equity-based awards. We measure share-based compensation expense of equity-based awards at fair value on the grant date on a straight-line basis over the vesting period. We account for restricted stock units that will be settled in cash as liability-based awards. We measure share-based compensation expense of liability-based awards at fair value at each reporting date until the date of settlement. Forfeitures are accounted for as they occur. As of September 30, 2020, the unamortized cost of outstanding equity-based restricted stock awards and restricted stock units was $2.6 million, which we expect to recognize over a weighted-average period of approximately 1.2 years. We repurchased 17,961 shares for $1.1 million during the nine months ended September 30, 2020 and 24,586 shares for $1.4 million during the nine months ended September 30, 2019 related to tax withholding requirements on vested share-based awards. Aggregate liabilities related to liability-based restricted stock units were $0.8 million as of September 30, 2020 and $0.4 million as of December 31, 2019. During the nine months ended September 30, 2020, restricted stock units vested, and we paid $0.2 million in cash and $0.8 million in shares. During the nine months ended September 30, 2019, restricted stock units vested, and we paid $0.3 million in cash and $0.2 million in shares. The following table summarizes the activity of the outstanding restricted stock awards and restricted stock units:
|  | Equity-Based Restricted Stock Awards |  |  | Equity-Based Restricted Stock Units |  |  | Liability-Based Restricted Stock Units |
|  | Shares |  |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  |  | Weighted-Average Grant Date Fair Value |
Balance at December 31, 2019 |  |  | 136,123 |  |  | $ | 52.66 |  |  |  | — |  |  | $ | — |  |  |  | 11,623 |  |  | $ | 52.17 |
Granted |  |  | 55,171 |  |  | $ | 51.06 |  |  |  | 232,435 |  |  | $ | 19.44 |  |  |  | 3,952 |  |  | $ | 50.43 |
Vested |  |  | (64,684 | ) |  | $ | 49.85 |  |  |  | (38,982 | ) |  | $ | 19.30 |  |  |  | (2,815 | ) |  | $ | 47.45 |
Forfeited |  |  | (15,192 | ) |  | $ | 56.54 |  |  |  | (2,183 | ) |  | $ | 19.30 |  |  |  | (1,634 | ) |  | $ | 56.59 |
Balance at September 30, 2020 |  |  | 111,418 |  |  | $ | 52.97 |  |  |  | 191,270 |  |  | $ | 19.47 |  |  |  | 11,126 |  |  | $ | 52.10 |
Stock Options We grant non-qualified stock options that are performance-based, as well as non-qualified options that are service-based. The performance-based awards are recognized on a straight-line basis over the performance period ranging from 1.4 to 3.4 years, and the underlying shares expected to be settled are adjusted each reporting period based on estimated future achievement of the respective performance metrics. The service-based awards are recognized on a straight-line basis over the requisite service period on a graded-vesting schedule over three years. The following table summarizes stock option activity:
|  | Shares |  |  | Weighted-Average Exercise Price |  |  | Aggregate Intrinsic Value(1) |
Options outstanding and exercisable at December 31, 2019 |  |  | 41,143 |  |  | $ | 16.62 |  |  |  |  |
Granted |  |  | 204,150 |  |  | $ | 19.98 |  |  |  |  |
Exercised |  |  | (41,143 | ) |  | $ | 16.62 |  |  |  |  |
Options outstanding at September 30, 2020 |  |  | 204,150 |  |  | $ | 19.98 |  |  | $ | 229,500 |
Options exercisable at September 30, 2020 |  |  | — |  |  | $ | — |  |  | $ | — |
(1) | The aggregate intrinsic value of stock options outstanding represents the difference between our closing stock price at the end of the reporting period and the exercise price, multiplied by the number of in-the-money stock options.
The following table summarizes stock options outstanding and exercisable as of September 30, 2020:
|  |  |  | Options Outstanding |  |  | Options Exercisable |
Range of exercise prices |  |  | Shares |  |  | Weighted-Average Remaining Contractual Life (in years) |  |  | Weighted-Average Exercise Price |  |  | Shares |  |  | Weighted-Average Exercise Price |
$ | 19.30 |  |  |  | 150,000 |  |  |  | 8.25 |  |  | $ | 19.30 |  |  |  | — |  |  | $ | — |
$ | 21.85 |  |  |  | 54,150 |  |  |  | 6.91 |  |  | $ | 21.85 |  |  |  | — |  |  | $ | — |
$19.30 - $21.85 |  |  |  | 204,150 |  |  |  | 7.89 |  |  | $ | 19.98 |  |  |  | — |  |  | $ | — |
The fair value of stock options granted in 2020 was estimated on the date of grant using the Black-Scholes option pricing model. Following is additional information on stock options and the underlying assumptions used in assessing fair value:
|  | Nine Months Ended |
|  | September 30, 2020 |
Assumptions used to estimate fair value of stock options granted: |  |  |  |
Risk-free interest rate |  | 0.27% - 0.31% |
Expected life |  | 4.3 - 5.4 years |
Expected volatility |  | 46.9% - 52.2% |
Expected dividend yield |  |  | — |
Weighted average grant-date fair value per share of options granted |  | $ | 8.38 |
Cash received from exercise of options (in thousands) |  | $ | 2,077 |
As of September 30, 2020, the total unrecognized compensation cost related to non-vested stock option awards was $1.6 million. We expect to recognize such costs over a weighted-average period of approximately 2.5 years. No stock options were granted in 2019.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration